FROM THE JOHNS HOPKINS UNIVERSITY PRESS
Science and Policy for the Twenty-first Century
edited by Jack E. Henningfield, Patricia B. Santora, and Warren K. Bickel
Our new book critically examines drug addiction treatment in the United States. We conceived this book to help revolutionize and energize debate and discussion about drug addiction treatment. Leading thinkers from many disciplines in the addiction field were asked to offer their perspectives on what addiction treatment could and should look like in the twenty-first century. We challenged our contributing authors to be creative and constructive by writing focused chapters, not technical review articles. We encouraged them to explore novel, promising, and, in some cases, provocative aspects of addiction treatment. Thirty-one leaders in the substance abuse and addiction field, including twelve of our program’s twenty Innovators, contributed chapters to the book.
Addiction Treatment highlights some of the most controversial issues in medicine:
Is addiction really a disease, a behavior, or just an excuse to use drugs?
Is stigmatizing addiction helpful or not?
Should cocaine-using pregnant women be locked up or treated for addiction?
What do people treated for drug addiction, asthma, diabetes, and high blood pressure have in common?
What does heroin production in Afghanistan have to do with crime in your city?
Jack E. Henningfield, PhD is an Adjunct Professor of Behavioral Biology and Director of the Innovators Combating Substance Abuse Program at the Johns Hopkins University School of Medicine, and Vice President for Research and Health Policy at Pinney Associates, a consulting firm in Bethesda, Maryland, that specializes in science policy and regulatory issues concerning public health, medication development, and treatment of tobacco addiction. Dr. Henningfield consults to GlaxoSmithKline on tobacco dependence treatment medications and has consulted to other pharmaceutical companies on drug dependence treatment through Pinney Associates. He is co-holder on a patent for a potential treatment for tobacco dependence.
Patricia B. Santora, PhD is an Assistant Professor of Psychiatry and Deputy Director of the Innovators Combating Substance Abuse Program at the Johns Hopkins University School of Medicine.
Warren K. Bickel, PhD is the Wilbur D. Mills Chair of Alcoholism and Drug Abuse Prevention, and is the Director of the Center for Substance Abuse Treatment at the University of Arkansas for Medical Sciences. Dr. Bickel is a principal of HealthSim LLC, and works with Catalyst Pharmaceutical Partners.
Click here for additional information and order form.